Search research articles
Contact Us
Filters
Showing results (11-20 of 52) with videos related to
Page
of 6
Sort By:
Scientific Reports
|
May 13, 2022
Serum levels of anti-PF4 IgG after AZD1222 (ChAdOx1 nCoV-19) vaccination
Taylor S Cohen, Elizabeth J Kelly, Sven Nylander, et al.
Vaccine
|
June 4, 2023
One year safety and immunogenicity of AZD1222 (ChAdOx1 nCoV-19): Final analysis of a randomized, placebo-controlled phase 1/2 trial in Japan
Kensuke Ishikawa, Maria-Claudia Nascimento, Michiko Asano, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy
|
June 6, 2017
Oncolytic VSV Primes Differential Responses to Immuno-oncology Therapy
Nicholas M Durham, Kathy Mulgrew, Kelly McGlinchey, et al.
International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases
|
October 24, 2021
Immunogenicity and safety of AZD1222 (ChAdOx1 nCoV-19) against SARS-CoV-2 in Japan: a double-blind, randomized controlled phase 1/2 trial
Michiko Asano, Hiroshi Okada, Yohji Itoh, et al.
Frontiers in Immunology
|
October 30, 2023
Fc-mediated functions of nirsevimab complement direct respiratory syncytial virus neutralization but are not required for optimal prophylactic protection
Tyler Brady, Corinne Cayatte, Tiffany L Roe, et al.
Physiological Genomics
|
March 8, 2012
Genetically determined heterogeneity of lung disease in a mouse model of airway mucus obstruction
Alessandra Livraghi-Butrico, Barbara R Grubb, Elizabeth J Kelly, et al.
Pediatrics
|
October 1, 2024
RSV Neutralizing Antibodies Following Nirsevimab and Palivizumab Dosing
Deidre Wilkins, Ulrika Wählby Hamrén, Yue Chang, et al.
Clinical & Translational Immunology
|
May 2, 2022
Validation and performance of a multiplex serology assay to quantify antibody responses following SARS-CoV-2 infection or vaccination
Deidre Wilkins, Anastasia A Aksyuk, Alexey Ruzin, et al.
Frontiers in Immunology
|
June 3, 2024
Seasonal human coronavirus humoral responses in AZD1222 (ChaAdOx1 nCoV-19) COVID-19 vaccinated adults reveal limited cross-immunity
Ann Marie Stanley, Anastasia A Aksyuk, Deidre Wilkins, et al.
Cell Reports. Medicine
|
January 7, 2023
AZD1222-induced nasal antibody responses are shaped by prior SARS-CoV-2 infection and correlate with virologic outcomes in breakthrough infection
Anastasia A Aksyuk, Himanshu Bansal, Deidre Wilkins, et al.
Page
of 6
Search research articles
Search
Showing results (11-20 of 52) with videos related to
Sort By:
Page
of 6
Scientific Reports
|
May 13, 2022
Serum levels of anti-PF4 IgG after AZD1222 (ChAdOx1 nCoV-19) vaccination
Taylor S Cohen, Elizabeth J Kelly, Sven Nylander, et al.
Vaccine
|
June 4, 2023
One year safety and immunogenicity of AZD1222 (ChAdOx1 nCoV-19): Final analysis of a randomized, placebo-controlled phase 1/2 trial in Japan
Kensuke Ishikawa, Maria-Claudia Nascimento, Michiko Asano, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy
|
June 6, 2017
Oncolytic VSV Primes Differential Responses to Immuno-oncology Therapy
Nicholas M Durham, Kathy Mulgrew, Kelly McGlinchey, et al.
International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases
|
October 24, 2021
Immunogenicity and safety of AZD1222 (ChAdOx1 nCoV-19) against SARS-CoV-2 in Japan: a double-blind, randomized controlled phase 1/2 trial
Michiko Asano, Hiroshi Okada, Yohji Itoh, et al.
Frontiers in Immunology
|
October 30, 2023
Fc-mediated functions of nirsevimab complement direct respiratory syncytial virus neutralization but are not required for optimal prophylactic protection
Tyler Brady, Corinne Cayatte, Tiffany L Roe, et al.
Physiological Genomics
|
March 8, 2012
Genetically determined heterogeneity of lung disease in a mouse model of airway mucus obstruction
Alessandra Livraghi-Butrico, Barbara R Grubb, Elizabeth J Kelly, et al.
Pediatrics
|
October 1, 2024
RSV Neutralizing Antibodies Following Nirsevimab and Palivizumab Dosing
Deidre Wilkins, Ulrika Wählby Hamrén, Yue Chang, et al.
Clinical & Translational Immunology
|
May 2, 2022
Validation and performance of a multiplex serology assay to quantify antibody responses following SARS-CoV-2 infection or vaccination
Deidre Wilkins, Anastasia A Aksyuk, Alexey Ruzin, et al.
Frontiers in Immunology
|
June 3, 2024
Seasonal human coronavirus humoral responses in AZD1222 (ChaAdOx1 nCoV-19) COVID-19 vaccinated adults reveal limited cross-immunity
Ann Marie Stanley, Anastasia A Aksyuk, Deidre Wilkins, et al.
Cell Reports. Medicine
|
January 7, 2023
AZD1222-induced nasal antibody responses are shaped by prior SARS-CoV-2 infection and correlate with virologic outcomes in breakthrough infection
Anastasia A Aksyuk, Himanshu Bansal, Deidre Wilkins, et al.
Page
of 6